Alpha Tau Medical Warrant (DRTSW)

• Market cap: $69.1M
• 1 day: 10.07%
• 5 days: -21.12%
• 1 month: -32.49%
• 3 months: -21.54%
• 6 months: 189.22%
• Year to date: 697.3%
• 1 year: 866.9%
• 5 years: 502.04%
• 10 years: 502.04%
• Sector: Healthcare
• Industry: Biotechnology

About: Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Employees: 121